articles Erectile dysfunction (ED) is defined as the consistent inability to achieve and/or maintain an erection sufficient for satisfactory sexual performance, over a 3-month period.
Model 2. ED is the primary illness, with loss of sexual function possibly leading to depressive symptoms.
Model 3.
Medical conditions, e.g. hypothyroidism, can result in both ED and depressive symptoms.
Model 4.
Depression and ED may be coincidentally comorbid. Although prevalence rates of ED and depression increase with age, they may be co-morbid in age groups other than the elderly.
However, sexual dysfunction is a common side-effect of antidepressant treatment, and may also explain the relationship between depression and ED. Serotonin reuptake inhibitors (SRIs), serotonin noradrenalin re-uptake inhibitors and tricyclic antidepressants are known to impact on sexual functioning (often leading to poor compliance and patient dissatisfaction). SRI-induced sexual dysfunction occurs in 30 -70% of patients treated for depression, while buproprion and nefazodone are associated with the least sexual dysfunction. 7 Antidepressant-induced sexual dysfunction may lead to premature discontinuation of treatment, raising the risk of relapse and recurrence of major depression.
There is also a high prevalence of anxiety in patients with ED, 8 and performance anxiety has been emphasised as a major cause of psychogenic ED, 9 with the effects on sexual arousal in men having been shown to be mediated largely by cognitive factors. 9 Two studies reported that approximately one-third of men with ED have a co-morbid psychiatric disorder, 6 predominantly affective disorder.
Even when the full diagnostic criteria are not met, there are high levels of anxiety and depressive symptoms. 6 Thus ED should be considered a multifactorial condition requiring a multidisciplinary approach and management.
The aim of the present study was to determine the prevalence of anxiety and depressive symptoms in men presenting with ED at the Men's Clinic International in Bloemfontein. Further aims were to determine the relationship, if any, between the severity of ED and mood/anxiety symptoms. We also hope to increase awareness of the co-morbidity of anxiety/mood symptoms and ED.
Material and methods
The study was an observational analytical study of 100
consecutive male patients of all ages presenting to the Men's Clinic International in Bloemfontein, South Africa with ED. The
Ethics Committee, Faculty of Health Sciences, of the University of the Free State approved the protocol for the study, and all study participants gave written informed consent.
Patients who did not give permission for the study and those who scored 20 or more on the 5-item intensity scale for ED were excluded from the study.
ED was scored using the International Index of Erectile Panic disorder, obsessive-compulsive disorder, generalised anxiety disorder and social phobia were rated using the Mini International Neuropsychiatric Interview (MINI). 13 During the research it was observed that the questions asked on the MINI rating scales were too direct for some of the clients and falsepositive answers were obtained. Non-direct questions were adopted and if a positive answer was obtained more direct questions from the MINI rating scale were asked to confirm the answer.
Results were summarised as frequencies and percentages (categorical variables) and means, standard deviations or percentiles (numerical variables). Associations were assessed by risk differences with 95% confidence intervals (CIs).
Results
Selected characteristics of the respondents are listed in Table I .
The majority (79%) were in the 30 -59-year age group. The majority were black (72%), married (75%) and employed (77%). Just under half of the respondents were active cigarette smokers (46%) and 70% reported consuming alcohol. Table II shows the severity of ED, risk factors for ED and comorbid psychiatric diagnosis. The majority of respondents had severe ED (57%); 36% had moderate ED, and 7% mild ED.
More than half of all respondents (60%) reported premature ejaculation.
Mild depressive symptoms were noted in 15 patients. A further 15 respondents had moderate depressive symptoms and 3 had severe depressive symptoms (Table II) . No psychiatric disorders were found in 58% of the respondents and 8 respondents only had mild depressive symptoms (Fig. 2) Under medical conditions 41% of participants suffered from hypertension, 17% from diabetes mellitus, 10% from hypercholesterolaemia and 5% from cardiovascular disease.
Only 2% of patients reported being treated for a psychiatric condition. The majority of these respondents were receiving medication for the relevant conditions. With regard to surgery, 2 respondents had coronary artery bypass grafts, 2 had stents inserted and 3 respondents had had prostatectomy performed in the past. Table III 
Discussion
The results of this study suggest that men suffering from ED are likely to have a co-morbid psychiatric disorder (42%, 95% CI:
32.2 -52.3%). Numerous studies have shown a high correlation between depression and ED, 1,2 and this study supports these findings, with 33% of the participants having depressive symptoms on the HAM-D. This is higher than the 15% lifetime prevalence of major depressive disorder occurring in men. 14 One of the difficulties experienced in this study was to find South African general population figures for depression and anxiety disorders for comparison, and therefore lifetime prevalence was used. The probability of depression seems to increase with the degree of ED. The co-morbidity of ED and depressive symptoms is also important as it affects compliance with treatment. Patients with ED and depressive symptoms are more likely to discontinue treatment for ED than patients with ED and no depressive symptoms. Twenty-one participants (21%, 95% CI: 13.5 -30.3%) were diagnosed with an anxiety disorder, which is slightly higher than the lifetime prevalence of anxiety disorder in men (19.2%).
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When subdivided into the specific anxiety disorders none of the individual anxiety disorders was higher than the lifetime prevalence. Anxiety disorders were only diagnosed in participants with moderate to severe ED. Twelve respondents had both depressive symptoms and an anxiety disorder,
showing that 36% of patients with depressive symptoms had a co-morbid anxiety disorder. In this study, the majority of men presenting with ED were between the ages of 30 and 59 years.
Although the risk of ED increases with age, it seems that ED causes more anxiety in this age group than in those above the age of 59 years. ED may adversely affect quality of life and impair social and occupational health to a greater extent in this group of respondents. Although not supported in this study, the risk of substance abuse in this group of men might also be higher.
It was interesting to note that 51% of respondents in the severe ED group reported suffering from premature ejaculation, compared with 70% of respondents in the mild and moderate groups. Premature ejaculation is another major stressor for respondents, causing significant distress, performance anxiety and interpersonal conflict. As this study has shown, depressive and anxiety disorders and concomitant medical conditions are common in men presenting with ED. As ED is a multifactorial condition, and we are unable to determine what comes first (ED, depression or medical condition), the treating physician should screen ED patients for affective and anxiety disorders. The physician should also assess patients with affective and anxiety disorders for ED.
Ideally the assessment of ED should occur before the commencement of psychotropic medication. Patients should also be screened routinely for medical conditions, namely hypertension, diabetes mellitus, hypercholesterolaemia and cardiac conditions. The treatment regimen for medical and psychiatric conditions should be altered to avoid side-effects of certain medications compounding the problem of ED.
As previously mentioned, the MINI rating scale was problematic as the questions were direct and respondents gave numerous false-positive answers. To prevent a false diagnosis, non-directive questions were asked to confirm positive answers obtained from the MINI. Should the present study be repeated, alternative anxiety rating scales could be used.
